General Drug Use-results Survey of Rituxan Intravenous Infusion - Systemic Sclerosis
Not Applicable
Recruiting
- Conditions
- Systemic sclerosis
- Registration Number
- JPRN-jRCT2031210659
- Lead Sponsor
- Ando Takashi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
Patients with systemic sclerosis who have received Rituxan intravenous infusion.
Exclusion Criteria
None
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of adverse events and adverse drug reactions.<br>Clinical global Impression - improvement, patient global Impression - improvement.
- Secondary Outcome Measures
Name Time Method